RT @Oncotarget: The cover for issue 37 of @Oncotarget features Figure 7, "The combination of romidepsin and KU60019 is synergistic in a xen…
RT @Oncotarget: The cover for issue 37 of @Oncotarget features Figure 7, "The combination of romidepsin and KU60019 is synergistic in a xen…
RT @Oncotarget: The cover for issue 37 of @Oncotarget features Figure 7, "The combination of romidepsin and KU60019 is synergistic in a xen…
RT @Oncotarget: The cover for issue 37 of @Oncotarget features Figure 7, "The combination of romidepsin and KU60019 is synergistic in a xen…
ATM inhibition overcomes resistance to histone deacetylase inhibitor due to p21 induction and cell cycle arrest. #lymphoma #lymsm https://t.co/0cVbptDiVp
The cover for issue 37 of @Oncotarget features Figure 7, "The combination of romidepsin and KU60019 is synergistic in a xenograft model of MCL," by Scotto, et al. https://t.co/EwNWMP1Bc3